GLORIA MELANIE (Chief Operating Officer) sold 7.3% of their position (17.71K shares) of IMMUNOVANT, INC. on the open market
Open‑market sale worth $678.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/26/2026ACC: 0001764013-26-000075
Officer· Chief Operating Officer
Since Feb 2026
-17.71K
Net shares
Net seller
$678.6K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
17.71K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−14.75K
Price / share
$38.18
Trade value
$563.08K
% of position
6.1%
6/26/2026
242.11K→227.36K
Common Stock
Direct
Shares
−2.97K
Price / share
$38.95
Trade value
$115.53K
% of position
1.3%
6/26/2026
227.36K→224.39K
Total
Net shares
−17.71K
Net value
-$678.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/26/2026 | S · Sale | −14.75K | $38.18 | $563.08K | 6.1% | 242.11K | 227.36K |
| Common Stock Direct | 6/26/2026 | S · Sale | −2.97K | $38.95 | $115.53K | 1.3% | 227.36K | 224.39K |
| Total | −17.71K | -$678.60K | ||||||
Derivative Transactions0
No derivative transactions reported